
|Articles|March 1, 1997
The American Journal of Managed Care
- March 1997
- Volume 3
- Issue 3
A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine
Advertisement
Articles in this issue
almost 29 years ago
The Political Economy of Capitated Managed Carealmost 29 years ago
Appropriate and Necessary Healthcare: New Language for a New Eraalmost 29 years ago
Managing Asthma CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
3
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
4
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
5














































